Exousia Pro, Inc. (MAJI)
OTCMKTS · Delayed Price · Currency is USD
0.0110
0.00 (0.00%)
May 18, 2026, 2:04 PM EST
Exousia Pro Market Cap
Exousia Pro has a market cap or net worth of $612.33 thousand as of May 19, 2026. Its market cap has decreased by -90.82% in one year.
Market Cap
612.33K
Enterprise Value
1.32M
Revenue
-12.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 2, 2011, Exousia Pro's market cap has decreased from 21.45M to 612.33K, a decrease of -97.15%. That is a compound annual growth rate of -21.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 598.88K | -73.43% |
| Dec 31, 2025 | 2.25M | 16.97% |
| Dec 31, 2024 | 1.93M | -50.14% |
| Dec 28, 2023 | 3.86M | 225.30% |
| Dec 30, 2022 | 1.19M | -58.10% |
| Dec 31, 2021 | 2.83M | -84.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 988.49K |
| Evofem Biosciences | 887.95K |
| Halberd | 822.03K |
| Emmaus Life Sciences | 808.29K |
| Windtree Therapeutics | 764.79K |
| SQZ Biotechnologies Company | 707.79K |
| Aibotics | 549.16K |
| Altamira Therapeutics | 467.53K |